SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013192
Filing Date
2023-08-03
Accepted
2023-08-03 16:03:07
Documents
95
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q coll-20230630x10q.htm   iXBRL 10-Q 2242000
2 EX-10.1 coll-20230630xex10d1.htm EX-10.1 192641
3 EX-31.1 coll-20230630xex31d1.htm EX-31.1 13077
4 EX-31.2 coll-20230630xex31d2.htm EX-31.2 13101
5 EX-32.1 coll-20230630xex32d1.htm EX-32.1 7655
6 EX-32.2 coll-20230630xex32d2.htm EX-32.2 7493
7 GRAPHIC coll-20230630x10q001.jpg GRAPHIC 9164
  Complete submission text file 0001558370-23-013192.txt   11221606

Data Files

Seq Description Document Type Size
8 EX-101.SCH coll-20230630.xsd EX-101.SCH 68195
9 EX-101.CAL coll-20230630_cal.xml EX-101.CAL 89487
10 EX-101.DEF coll-20230630_def.xml EX-101.DEF 290864
11 EX-101.LAB coll-20230630_lab.xml EX-101.LAB 576667
12 EX-101.PRE coll-20230630_pre.xml EX-101.PRE 462959
89 EXTRACTED XBRL INSTANCE DOCUMENT coll-20230630x10q_htm.xml XML 2313042
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37372 | Film No.: 231139779
SIC: 2834 Pharmaceutical Preparations